SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2002
BioTransplant Incorporated
--------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-28324 04-3119555
----------------------------------- ----------------------------------- -------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
Building 75, Third Avenue
Charlestown Navy Yard
Charlestown, MA 02129
------------------------------------- -----------------------------------
(Address of principal (Zip Code)
executive offices)
Registrant's telephone number, including area code: (617) 241-5200
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
On July 22, 2002, BioTransplant Incorporated (the "Company") issued a
press release announcing that its Board of Directors had elected Donald B.
Hawthorne to the position of President and Chief Executive Officer of the
Company. See the press release attached hereto as Exhibit 99.1.
On July 29, 2002, the Company issued a press release announcing a
restructuring plan, which includes a reduction in workforce, intended to
streamline the Company's operations around a new strategic focus. See the press
release attached hereto as Exhibit 99.2.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits.
See Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: August 2, 2002 BIOTRANSPLANT INCORPORATED
By: /s/ Donald B. Hawthorne
--------------------------
Donald B. Hawthorne
President and Chief
Executive Officer
EXHIBIT INDEX
Exhibit No. Exhibit
----------- -------
Exhibit 99.1 Press Release dated July 22, 2002
Exhibit 99.2 Press Release dated July 29, 2002